$PSNL stock has now fallen 10% today, according to our price data from Polygon. There has been approximately $7,472,771 of trading volume.
Here is what we see in our data on $PSNL (you can track the company live on Quiver's $PSNL stock page):
$PSNL Insider Trading Activity
$PSNL insiders have traded $PSNL stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $PSNL stock by insiders over the last 6 months:
- AARON TACHIBANA (CFO AND COO) has made 0 purchases and 2 sales selling 104,309 shares for an estimated $1,121,752.
- CHRISTOPHER M HALL (PRESIDENT AND CEO) sold 29,612 shares for an estimated $266,211
- RICHARD CHEN (CHIEF MEDICAL OFFICER AND EVP) sold 452 shares for an estimated $2,969
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PSNL Hedge Fund Activity
We have seen 50 institutional investors add shares of $PSNL stock to their portfolio, and 78 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,619,121 shares (+128.0%) to their portfolio in Q3 2025, for an estimated $10,556,668
- KENNEDY CAPITAL MANAGEMENT LLC added 1,281,695 shares (+196.2%) to their portfolio in Q3 2025, for an estimated $8,356,651
- ARK INVESTMENT MANAGEMENT LLC added 802,268 shares (+11.3%) to their portfolio in Q3 2025, for an estimated $5,230,787
- MARSHALL WACE, LLP removed 696,286 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $4,567,636
- ABERDEEN GROUP PLC added 628,450 shares (+35.7%) to their portfolio in Q3 2025, for an estimated $4,097,493
- BLACKROCK, INC. added 440,806 shares (+8.5%) to their portfolio in Q3 2025, for an estimated $2,874,055
- EXODUSPOINT CAPITAL MANAGEMENT, LP removed 437,369 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $2,851,645
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PSNL Government Contracts
We have seen $13,834,000 of award payments to $PSNL over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- WHOLE GENOME SEQUENCING: $13,500,000
- WHOLE GENOME SEQUENCING: $334,000
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$PSNL Analyst Ratings
Wall Street analysts have issued reports on $PSNL in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 11/06/2025
- BTIG issued a "Buy" rating on 10/22/2025
To track analyst ratings and price targets for $PSNL, check out Quiver Quantitative's $PSNL forecast page.
$PSNL Price Targets
Multiple analysts have issued price targets for $PSNL recently. We have seen 5 analysts offer price targets for $PSNL in the last 6 months, with a median target of $12.0.
Here are some recent targets:
- Tejas Savant from Morgan Stanley set a target price of $11.0 on 12/02/2025
- Subbu Nambi from Guggenheim set a target price of $12.0 on 11/11/2025
- Swayampakula Ramakanth from HC Wainwright & Co. set a target price of $13.0 on 11/11/2025
- Mark Massaro from BTIG set a target price of $12.0 on 11/11/2025
- Mike Matson from Needham set a target price of $10.0 on 11/05/2025
You can track data on $PSNL on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
